HEALTHEQUITY, INC. Quarterly Nonoperating Income (Expense) in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Healthequity, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2015 to Q3 2024.
  • Healthequity, Inc. Nonoperating Income (Expense) for the quarter ending October 31, 2024 was -$13.4M, a 36.8% decline year-over-year.
  • Healthequity, Inc. Nonoperating Income (Expense) for the twelve months ending October 31, 2024 was -$43.3M, a 7.32% increase year-over-year.
  • Healthequity, Inc. annual Nonoperating Income (Expense) for 2023 was -$42.7M, a 9.53% increase from 2022.
  • Healthequity, Inc. annual Nonoperating Income (Expense) for 2022 was -$47.2M, a 10.9% decline from 2021.
  • Healthequity, Inc. annual Nonoperating Income (Expense) for 2021 was -$42.5M, a 42.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$43.3M -$13.4M -$3.6M -36.8% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-09
Q2 2024 -$39.7M -$12.3M -$1.8M -17.1% May 1, 2024 Jul 31, 2024 10-Q 2024-09-03
Q1 2024 -$37.9M -$8.39M +$4.78M +36.3% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-03
Q4 2023 -$42.7M -$9.17M +$4.04M +30.6% Nov 1, 2023 Jan 31, 2024 10-K 2024-03-22
Q3 2023 -$46.7M -$9.8M +$1.92M +16.4% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-09
Q2 2023 -$48.6M -$10.5M +$945K +8.25% May 1, 2023 Jul 31, 2023 10-Q 2024-09-03
Q1 2023 -$49.6M -$13.2M -$2.41M -22.4% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-03
Q4 2022 -$47.2M -$13.2M +$3.31M +20% Nov 1, 2022 Jan 31, 2023 10-K 2024-03-22
Q3 2022 -$50.5M -$11.7M -$2.96M -33.8% Aug 1, 2022 Oct 31, 2022 10-K 2024-03-22
Q2 2022 -$47.5M -$11.5M -$4.55M -65.9% May 1, 2022 Jul 31, 2022 10-K 2024-03-22
Q1 2022 -$42.9M -$10.8M -$443K -4.29% Feb 1, 2022 Apr 30, 2022 10-K 2024-03-22
Q4 2021 -$42.5M -$16.5M -$16.8M -6841% Nov 1, 2021 Jan 31, 2022 10-K 2024-03-22
Q3 2021 -$25.7M -$8.76M -$1.39M -18.8% Aug 1, 2021 Oct 31, 2021 10-K 2024-03-22
Q2 2021 -$24.4M -$6.91M +$2.81M +28.9% May 1, 2021 Jul 31, 2021 10-K 2024-03-22
Q1 2021 -$27.2M -$10.3M +$2.71M +20.8% Feb 1, 2021 Apr 30, 2021 10-K 2024-03-22
Q4 2020 -$29.9M $245K +$15.4M Nov 1, 2020 Jan 31, 2021 10-K 2023-03-30
Q3 2020 -$45.3M -$7.37M +$33.8M +82.1% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-09
Q2 2020 -$79.1M -$9.72M -$8.59M -762% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q1 2020 -$70.5M -$13M -$36.6M -155% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-08
Q4 2019 -$33.9M -$15.1M -$14.9M -6755% Nov 1, 2019 Jan 31, 2020 10-K 2020-03-31
Q3 2019 -$18.9M -$41.2M -$39.6M -2548% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-09
Q2 2019 $20.7M -$1.13M -$1.05M -1404% May 1, 2019 Jul 31, 2019 10-Q 2020-09-09
Q1 2019 $21.7M $23.6M +$23.6M Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-04
Q4 2018 -$1.85M -$221K +$1.49M +87% Nov 1, 2018 Jan 31, 2019 10-K 2020-03-31
Q3 2018 -$3.34M -$1.56M -$1.16M -294% Aug 1, 2018 Oct 31, 2018 10-K 2020-03-31
Q2 2018 -$2.18M -$75K -$37K -97.4% May 1, 2018 Jul 31, 2018 10-K 2020-03-31
Q1 2018 -$2.14M -$1K* +$89K Feb 1, 2018 Apr 30, 2018 10-K 2020-03-31
Q4 2017 -$2.23M -$1.71M Nov 1, 2017 Jan 31, 2018 10-K 2020-03-31
Q3 2017 -$395K -$139K -54.3% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-06
Q2 2017 -$38K -$1K -2.7% May 1, 2017 Jul 31, 2017 10-Q 2018-09-06
Q1 2017 -$90K +$551K +86% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
Q3 2016 -$256K -$377K -312% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q2 2016 -$37K May 1, 2016 Jul 31, 2016 10-Q 2017-09-07
Q1 2016 -$641K Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q3 2015 $121K Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.